Skip to main content

Table 3 Comparison of the REE between study groups before and after the intervention

From: The effect of omega3 fatty acid supplementation on PPARγ and UCP2 expressions, resting energy expenditure, and appetite in athletes

Variable

Omega-3 Group (n = 18)

Placebo Group (n = 18)

MD (95% CI), P

VO2 max (mL/kg/min)

 Before

264 (61.1)

219 (57.9)

44.9 (4.62, 85.2), 0.98b

 After

280 (66.6)

225 (48.9)

54.5, (14.9, 94.1), 0.01a

 MD (95% CI), pa

−15.7 (−29.5, − 1.94), 0.03

−6.17 (−23.3, 11.0), 0.46

 

REE (kcal/day)

 Before

1792 (311)

1527 (404)

265 (20.4, 509), 0.98b

 After

2012 (401)

1557 (344)

454 (201, 708), 0.01c

MD (95% CI), pa

− 220(−341, −98.3), 0.01

−30.6(−181, 120), 0.67

 

REE%

 Before

99.5 (20.1)

85.3 (22.2)

14.1 (− 0.27, 28.5), 0.05b

 After

110 (23.1)

87.3 (19.7)

22.8 (8.27, 37.3), 0.01c

 MD (95% CI), pa

−10.6(−16.1, −5.14), 0.01

− 1.94(− 7.79, 3.90), 0.49

 
  1. Data are presented as Mean (standard deviation)
  2. a p based on paired samples t-test
  3. b p based on independent-samples t-test
  4. c based on ANCOVA adjusted for baseline values
  5. CI confidence of interval, MD mean differences, REE resting energy expenditure, VO2 max Maximal oxygen consumption